Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Anticoagulant Selection Is Cornerstone of Pulmonary Embolism Treatment

By Lauren Westafer, DO, MPH, MS, FACEP | on March 11, 2025 | 1 Comment
Practice Changers
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version
You Might Also Like
  • ACEP Clinical Policy Review: Suspected Pulmonary Embolism
  • A Rational Approach to Pulmonary Embolism Evaluation
  • Reversal of Anticoagulation
Explore This Issue
ACEP Now: March 02

Pages: 1 2 3 | Single Page

Topics: AnticoagulantsClinicalDirect Oral Anticoagulantsheparinintravenous unfractionated heparin (UFH)low-molecular– weight heparinsPulmonary Embolism

Related

  • PCC versus Andexanet Alfa for Factor Xa Reversal

    October 9, 2025 - 0 Comment
  • Non-Invasive Positive Pressure Ventilation in the Emergency Department

    October 1, 2025 - 0 Comment
  • Emergency Department Management of Prehospital Tourniquets

    October 1, 2025 - 0 Comment

Current Issue

ACEP Now: November 2025

Download PDF

Read More

One Response to “Anticoagulant Selection Is Cornerstone of Pulmonary Embolism Treatment”

  1. March 23, 2025

    David McClellan Reply

    This comment is true as far as it goes LMWH would certainly be better than unfractionated heparin in most cases. I think giving short shift to the Dorax is a serious deficiency. Using DOACs enables you to briefly observe the patient in the emergency department to send them home with lower risk, pulmonary embolism and almost all other VT’s with quite significant safety as has been previously proven and numerous studies.

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603